1887

Journal of General Virology header logo

Volume 99, Issue 12

Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo Open Access

Abstract

Until recently, our understanding of the cellular tropism of human norovirus (HuNoV), a major cause of viral gastroenteritis, has been limited. Immune cells and intestinal epithelial cells (IECs) have been proposed as targets of HuNoV replication in vivo, although the contribution of each to pathogenesis and transmission is unknown. Murine norovirus (MNV) is widely used as a surrogate model for HuNoV, as it replicates in cultured immune cells. The importance of the complete MNV immune cell tropism in vivo has not been determined. Recent work has linked replication in IECs to viral persistence in vivo. MNV provides a model to assess the relative contribution of each cell tropism to viral replication in immunocompetent native hosts. Here we exploited cell-specific microRNAs to control MNV replication, through insertion of microRNA target sequences into the MNV genome. We demonstrated the utility of this approach for MNV in vitro by selectively reducing replication in microglial cells, using microglial-specific miR-467c. We then showed that inserting a target sequence for the haematopoietic-specific miR-142-3p abrogated replication in a macrophage cell line. The presence of a target sequence for either miR-142-3p or IEC miR-215 significantly reduced viral secretion during the early stages of a persistent infection in immunocompetent mice, confirming that both cell types support viral replication in vivo. This study provides additional evidence that MNV shares the IEC tropism of HuNoVs in vivo, and now provides a model to dissect the contribution of replication in each cell type to viral pathogenesis and transmission in a native host.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): epithelial cells , haematopoetic cells , microRNA , Norovirus and tropism
© 2018 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001065
2018-04-23
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/12/1621.html?itemId=/content/journal/jgv/10.1099/jgv.0.001065&mimeType=html&fmt=ahah

References

  1. Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14:725–730 [View Article][PubMed]
     [Google Scholar]
  2. Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D et al. Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. Am J Epidemiol 2010; 171:1014–1022 [View Article][PubMed]
     [Google Scholar]
  3. Harris JP, Adams NL, Lopman BA, Allen DJ, Adak GK. The development of Web-based surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England. Epidemiol Infect 2014; 142:1590–1598 [View Article][PubMed]
     [Google Scholar]
  4. Lee LY, Ladner DP, Ison MG. Norovirus infection in solid organ transplant recipients: a single-center retrospective study. Transpl Infect Dis 2016; 18:932–938 [View Article][PubMed]
     [Google Scholar]
  5. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinjé J et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224–1231 [View Article][PubMed]
     [Google Scholar]
  6. Rouhani S, Peñataro Yori P, Paredes Olortegui M, Siguas Salas M, Rengifo Trigoso D et al. Norovirus infection and acquired immunity in 8 countries: results from the maL-ED study. Clin Infect Dis 2016; 62:1210–1217 [View Article][PubMed]
     [Google Scholar]
  7. Lopman BA, Grassly NC. Editorial commentary: pediatric norovirus in developing countries: a picture slowly comes into focus. Clin Infect Dis 2016; 62:1218–1220 [View Article][PubMed]
     [Google Scholar]
  8. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972; 10:1075–1081[PubMed]
     [Google Scholar]
  9. Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 2016; 353:1387–1393 [View Article][PubMed]
     [Google Scholar]
  10. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 2014; 346:755–759 [View Article][PubMed]
     [Google Scholar]
  11. Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B et al. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol 2016; 97:2291–2300 [View Article][PubMed]
     [Google Scholar]
  12. Taube S, Kolawole AO, Höhne M, Wilkinson JE, Handley SA et al. A mouse model for human norovirus. mBio 2013; 4:e00450-13 [View Article][PubMed]
     [Google Scholar]
  13. Bok K, Parra GI, Mitra T, Abente E, Shaver CK et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA 2011; 108:325–330 [View Article][PubMed]
     [Google Scholar]
  14. Seo DJ, Jung D, Jung S, Ha SK, Ha SD et al. Experimental miniature piglet model for the infection of human norovirus GII. J Med Virol 2018; 90:655–662 [View Article][PubMed]
     [Google Scholar]
  15. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP et al. Laboratory efforts to cultivate noroviruses. J Gen Virol 2004; 85:79–87 [View Article][PubMed]
     [Google Scholar]
  16. Leung WK, Chan PK, Lee NL, Sung JJ. Development of an in vitro cell culture model for human noroviruses and its clinical application. Hong Kong Med J 2010; 16:18–21[PubMed]
     [Google Scholar]
  17. Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN et al. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis 2013; 19:431–438 [View Article][PubMed]
     [Google Scholar]
  18. Cheetham S, Souza M, Meulia T, Grimes S, Han MG et al. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 2006; 80:10372–10381 [View Article][PubMed]
     [Google Scholar]
  19. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV et al. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2004; 2:e432 [View Article][PubMed]
     [Google Scholar]
  20. Chaudhry Y, Skinner MA, Goodfellow IG. Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol 2007; 88:2091–2100 [View Article][PubMed]
     [Google Scholar]
  21. Arias A, Bailey D, Chaudhry Y, Goodfellow I. Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon. J Gen Virol 2012; 93:1432–1441 [View Article][PubMed]
     [Google Scholar]
  22. Grau KR, Roth AN, Zhu S, Hernandez A, Colliou N et al. The major targets of acute norovirus infection are immune cells in the gut-associated lymphoid tissue. Nat Microbiol 2017; 2:1586–1591 [View Article][PubMed]
     [Google Scholar]
  23. Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER et al. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol 2007; 81:10460–10473 [View Article][PubMed]
     [Google Scholar]
  24. Elftman MD, Gonzalez-Hernandez MB, Kamada N, Perkins C, Henderson KS et al. Multiple effects of dendritic cell depletion on murine norovirus infection. J Gen Virol 2013; 94:1761–1768 [View Article][PubMed]
     [Google Scholar]
  25. Gonzalez-Hernandez MB, Liu T, Blanco LP, Auble H, Payne HC et al. Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M-like cells. J Virol 2013; 87:12685–12693 [View Article][PubMed]
     [Google Scholar]
  26. Gonzalez-Hernandez MB, Liu T, Payne HC, Stencel-Baerenwald JE, Ikizler M et al. Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells. J Virol 2014; 88:6934–6943 [View Article][PubMed]
     [Google Scholar]
  27. Lee S, Wilen CB, Orvedahl A, McCune BT, Kim KW et al. Norovirus cell tropism is determined by combinatorial action of a viral non-structural protein and host cytokine. Cell Host Microbe 2017; 22:449–459 [View Article][PubMed]
     [Google Scholar]
  28. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008; 4:239248 [View Article][PubMed]
     [Google Scholar]
  29. Heiss BL, Maximova OA, Pletnev AG. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J Virol 2011; 85:1464–1472 [View Article][PubMed]
     [Google Scholar]
  30. Yen LC, Lin YL, Sung HH, Liao JT, Tsao CH et al. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine 2013; 31:18:18 [View Article][PubMed]
     [Google Scholar]
  31. Ylösmäki E, Martikainen M, Hinkkanen A, Saksela K. Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting. J Virol 2013; 87:335–344 [View Article][PubMed]
     [Google Scholar]
  32. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J et al. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 2009; 27:572–576 [View Article][PubMed]
     [Google Scholar]
  33. Pham AM, Langlois RA, Tenoever BR. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog 2012; 8:e1002465 [View Article][PubMed]
     [Google Scholar]
  34. Kelly EJ, Hadac EM, Greiner S, Russell SJ. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 2008; 14:1278–1283 [View Article][PubMed]
     [Google Scholar]
  35. Kelly EJ, Nace R, Barber GN, Russell SJ. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol 2010; 84:1550–1562 [View Article][PubMed]
     [Google Scholar]
  36. Lee CY, Rennie PS, Jia WW. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Clin Cancer Res 2009; 15:5126–5135 [View Article][PubMed]
     [Google Scholar]
  37. Ylösmäki E, Lavilla-Alonso S, Jäämaa S, Vähä-Koskela M, Af Hällström T et al. MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver. PLoS One 2013; 8:22 [View Article][PubMed]
     [Google Scholar]
  38. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104:1604–1609 [View Article][PubMed]
     [Google Scholar]
  39. Wang P, Hou J, Lin L, Wang C, Liu X et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 2010; 185:6226–6233 [View Article][PubMed]
     [Google Scholar]
  40. Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 2010; 24:2292–2300 [View Article][PubMed]
     [Google Scholar]
  41. Witwer KW, Sisk JM, Gama L, Clements JE. MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol 2010; 184:2369–2376 [View Article][PubMed]
     [Google Scholar]
  42. McFadden N, Bailey D, Carrara G, Benson A, Chaudhry Y et al. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog 2011; 7:e1002413 [View Article][PubMed]
     [Google Scholar]
  43. Thorne L, Bailey D, Goodfellow I. High-resolution functional profiling of the norovirus genome. J Virol 2012; 86:11441–11456 [View Article][PubMed]
     [Google Scholar]
  44. McCune BT, Tang W, Lu J, Eaglesham JB, Thorne L et al. Noroviruses Co-opt the function of host proteins VAPA and VAPB for replication via a phenylalanine-phenylalanine-acidic-tract-motif mimic in nonstructural viral protein NS1/2. mBio 2017; 8:e00668-17 [View Article][PubMed]
     [Google Scholar]
  45. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129:1401–1414 [View Article][PubMed]
     [Google Scholar]
  46. McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010; 139:1654–1664 [View Article][PubMed]
     [Google Scholar]
  47. Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science 2015; 347:1258100 [View Article][PubMed]
     [Google Scholar]
  48. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science 2015; 347:266–269 [View Article][PubMed]
     [Google Scholar]
  49. Nice TJ, Strong DW, McCune BT, Pohl CS, Virgin HW. A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol 2013; 87:327–334 [View Article][PubMed]
     [Google Scholar]
  50. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003; 299:1575–1578 [View Article][PubMed]
     [Google Scholar]
  51. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE et al. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol 2007; 81:3251–3263 [View Article][PubMed]
     [Google Scholar]
  52. Bailey D, Karakasiliotis I, Vashist S, Chung LM, Rees J et al. Functional analysis of RNA structures present at the 3' extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence. J Virol 2010; 84:2859–2870 [View Article][PubMed]
     [Google Scholar]
  53. Langlois RA, Albrecht RA, Kimble B, Sutton T, Shapiro JS et al. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat Biotechnol 2013; 31:844–847 [View Article][PubMed]
     [Google Scholar]
  54. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007; 25:1457–1467 [View Article][PubMed]
     [Google Scholar]
  55. Orchard RC, Wilen CB, Doench JG, Baldridge MT, McCune BT et al. Discovery of a proteinaceous cellular receptor for a norovirus. Science 2016; 353:933–936 [View Article][PubMed]
     [Google Scholar]
  56. Guix S, Asanaka M, Katayama K, Crawford SE, Neill FH et al. Norwalk virus RNA is infectious in mammalian cells. J Virol 2007; 81:12238–12248 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001065
Loading
Targeting macrophage- and intestinal epithelial cell-specific microRNAs against norovirus restricts replication in vivo
J. Gen. Virol. 99, 1621 (2018); https://doi.org/10.1099/jgv.0.001065
/content/journal/jgv/10.1099/jgv.0.001065
/content/journal/jgv/10.1099/jgv.0.001065
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error